ArticleInternational journal of breast cancer2012
Management and outcomes of male breast cancer in zaria, Nigeria.
Article in International journal of breast cancer, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers, 4 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
14 citing papers in PubMed, 4 syntheses or guidelines pooled it, 41 citations in OpenAlex.
- 5-year survival rate and determinants of decreased survival among patients with breast cancer in Africa: a systematic review and meta-analysis.BMJ global health · 2026Pooled it
- Survival Patterns Among Patients With Breast Cancer in Sub-Saharan Africa: A Systematic Review and Meta-Analysis.JAMA network open · 2024Pooled it
- Experiences and perceptions of men following breast cancer diagnosis: a mixed method systematic review.BMC cancer · 2024Pooled it
- Pooled it
- Male breast cancer: a 30 year retrospective analysis from a tertiary cancer care centre.Ecancermedicalscience · 2023Article
- Current state of surgical management for male breast cancer.Translational cancer research · 2019Review
- Breast diseases histologically diagnosed at a tertiary facility in Uganda (2005-2014).BMC cancer · 2018Article
- Male breast cancer: diagnosis stages, treatment and survival in a country with limited resources (Burkina Faso).World journal of surgical oncology · 2018Article
- Men Have a Higher Incidence of Seroma after Breast Cancer SurgeryAsian Pacific journal of cancer prevention : APJCP · 2017Article
- The Management and Outcomes of Male Breast Cancer.The journal of breast health · 2016Article
- Male breast cancer: a clinicopathological study of an Egyptian population (Alexandria experience).Contemporary oncology (Poznan, Poland) · 2016Article
- Cerebral Metastasis from Breast Cancer in a Male Patient with HIV.Case reports in neurological medicine · 2015Article
- Epidemiologic and Clinical Profiles of Breast Diseases in Niger.International journal of cancer and oncology · 2015Article
- ADVANCED, RECURRENT, INVASIVE CRIBIFORM CARCINOMA OF THE BREAST IN A 17-YEAR-OLD MALE: A CASE REPORT.Journal of the West African College of SurgeonsArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Male breast cancer is an uncommon disease accounting for only 1% of all breast cancers. We present the evaluation, treatment and outcome of male patients seen with breast cancer in our institution. Male patients that had histological diagnosis of breast cancer from 2001 to 2010 were retrospectively evaluated. After evaluation patients were treated with modified radical mastectomy. Combination chemotherapy was given to patients with positive axillary lymph nodes. Radiotherapy and hormonal therapy were also employed. There were 57 male patients with breast cancer which accounted for 9% of all breast cancers seen during the study period. Their mean age was 59 ± 2.3 years. The mean tumor diameter was 13 ± 2.5 cm. Fifty three (93%) patients presented with advanced disease including 15 with distant metastasis. Four patients with stage II disease were treated with modified radical mastectomy, chemotherapy and tamoxifen. Of the 30 patients with sage III disease that had modified radical mastectomy, complete axillary clearance and tumor free margins were achieved in 25. Overall 21 (36.8%) patients were tumor free at one year. Overall 5-year survival was 22.8%. In conclusion, male patients with breast cancer present with advanced disease which is associated with poor outcome of treatment.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.